Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$13.68
-0.04-0.29%
At close: -
$13.68
0.000.00%
After Hours: Mar 28, 4:00 PM EDT
Comments
Loading...
Dynavax Technologies Analyst Ratings and Price Targets | NASDAQ:DVAX | Benzinga
Dynavax Technologies Corp has a consensus price target of $24.8 based on the ratings of 5 analysts. The high is $33 issued by Citizens Capital Markets on February 21, 2025. The low is $12 issued by Goldman Sachs on February 11, 2025. The 3 most-recent analyst ratings were released by Citizens Capital Markets, HC Wainwright & Co., and Goldman Sachs on February 21, 2025, February 21, 2025, and February 11, 2025, respectively. With an average price target of $25.33 between Citizens Capital Markets, HC Wainwright & Co., and Goldman Sachs, there's an implied 85.19% upside for Dynavax Technologies Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citizens Capital Markets
HC Wainwright & Co.
Goldman Sachs
JMP Securities
Goldman Sachs
1calculated from analyst ratings
Analyst Ratings for Dynavax Technologies
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/21/2025 | Buy Now | 141.23% | Citizens Capital Markets | Jason Butler55% | $29 → $33 | Maintains | Market Outperform | Get Alert |
| 02/21/2025 | Buy Now | 126.61% | HC Wainwright & Co. | Edward White52% | $31 → $31 | Reiterates | Buy → Buy | Get Alert |
| 02/11/2025 | Buy Now | -12.28% | Goldman Sachs | Paul Choi57% | $15 → $12 | Downgrade | Neutral → Sell | Get Alert |
| 01/14/2025 | Buy Now | 126.61% | HC Wainwright & Co. | Edward White52% | $29 → $31 | Maintains | Buy | Get Alert |
| 11/08/2024 | Buy Now | 111.99% | HC Wainwright & Co. | Edward White52% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 10/15/2024 | Buy Now | 111.99% | HC Wainwright & Co. | Edward White52% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2024 | Buy Now | 9.65% | Goldman Sachs | Paul Choi57% | $20 → $15 | Maintains | Neutral | Get Alert |
| 08/07/2024 | Buy Now | 111.99% | HC Wainwright & Co. | Edward White52% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 06/28/2024 | Buy Now | 111.99% | HC Wainwright & Co. | Edward White52% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | 111.99% | HC Wainwright & Co. | Edward White52% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | 111.99% | HC Wainwright & Co. | Edward White52% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 02/01/2024 | Buy Now | 46.2% | Goldman Sachs | Paul Choi57% | → $20 | Initiates | → Neutral | Get Alert |
| 11/03/2023 | Buy Now | 97.37% | JMP Securities | Roy Buchanan36% | $25 → $27 | Maintains | Market Outperform | Get Alert |
| 11/03/2023 | Buy Now | 104.68% | HC Wainwright & Co. | Edward White52% | $27 → $28 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | 97.37% | HC Wainwright & Co. | Edward White52% | → $27 | Reiterates | Buy → Buy | Get Alert |
| 08/04/2023 | Buy Now | 82.75% | JMP Securities | Roy Buchanan36% | $24 → $25 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | 75.44% | JMP Securities | Roy Buchanan36% | $25 → $24 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | 97.37% | HC Wainwright & Co. | Edward White52% | → $27 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | Buy Now | 82.75% | JMP Securities | Roy Buchanan36% | $22 → $25 | Maintains | Market Outperform | Get Alert |
| 02/24/2023 | Buy Now | 97.37% | HC Wainwright & Co. | Edward White52% | $28 → $27 | Maintains | Buy | Get Alert |
| 11/04/2022 | Buy Now | 53.51% | Goldman Sachs | Madhu Kumar72% | $24 → $21 | Maintains | Buy | Get Alert |
| 09/27/2022 | Buy Now | 60.82% | JMP Securities | Roy Buchanan36% | → $22 | Initiates | → Market Outperform | Get Alert |
FAQ
What is the target price for Dynavax Technologies (DVAX) stock?
The latest price target for Dynavax Technologies (NASDAQ:DVAX) was reported by Citizens Capital Markets on February 21, 2025. The analyst firm set a price target for $33.00 expecting DVAX to rise to within 12 months (a possible 141.23% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Dynavax Technologies (DVAX)?
The latest analyst rating for Dynavax Technologies (NASDAQ:DVAX) was provided by Citizens Capital Markets, and Dynavax Technologies maintained their market outperform rating.
When was the last upgrade for Dynavax Technologies (DVAX)?
There is no last upgrade for Dynavax Technologies
When was the last downgrade for Dynavax Technologies (DVAX)?
The last downgrade for Dynavax Technologies Corp happened on February 11, 2025 when Goldman Sachs changed their price target from $15 to $12 for Dynavax Technologies Corp.
When is the next analyst rating going to be posted or updated for Dynavax Technologies (DVAX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dynavax Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dynavax Technologies was filed on February 21, 2025 so you should expect the next rating to be made available sometime around February 21, 2026.
Is the Analyst Rating Dynavax Technologies (DVAX) correct?
While ratings are subjective and will change, the latest Dynavax Technologies (DVAX) rating was a maintained with a price target of $29.00 to $33.00. The current price Dynavax Technologies (DVAX) is trading at is $13.68, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.